Survivin is an inhibitor of apoptosis protein that also plays critical roles in regulating the cell cycle and mitosis. Its prominent expression in essentially all human malignancies, and low or absent expression in most normal tissues, suggests that it would be an ideal target for cancerdirected therapy. Impeding development of safe and effective survivin antagonists for clinical use is a lack of understanding of the molecular mechanisms by which survivin differentially affects apoptosis and cell division, in normal and malignant cells. We show that the diverse functional roles of survivin can be explained, in part, by its heterodimerization with survivin splice variants in tumor cells. Survivin and survivin-DEx3 interact within the mitochondria where they may inhibit mitochondrialdependent apoptosis. If the expression of all survivin forms is eliminated by siRNA transfections, cells undergo both apoptosis and defective cell division. Overall, we provide new insights suggesting that targeting specific survivin isoforms, rather than survivin alone, may selectively and effectively destroy tumor cells. These findings are likely to have a significant impact in the design of biologic agents for clinical therapy.
Introduction
Survivin was originally identified by its structural homology to the inhibitor of apoptosis (IAP) family of proteins in human B-cell lymphoma (Ambrosini et al., 1997) . The major protein expressed from the survivin gene locus is approximately 16.5 kDa, making it the smallest known member of the mammalian IAP family (LaCasse et al., 1998) . Structurally, it is composed of a single BIR domain and an extended COOH-terminal a-helical coiled-coil domain (LaCasse et al., 1998) . It does not contain a RING-finger domain, found in other IAP protein members. Transcription from the survivin gene locus gives rise to alternatively spliced transcripts, described in both humans and mice (Mahotka et al., 1999; Badran et al., 2004) . Of the human splice variants, survivin-2B is generated by the insertion of an alternative exon; survinin-DEx-3 arises from the removal of exon 3; and survivin-3B results from the introduction of a novel exon 3B (Figure 1 ) (Mahotka et al., 1999; Badran et al., 2004) . Little is known about the differential function or the differential expression of the survinin alternative splice forms or how they might interact with other proteins or themselves.
In many cells, survivin shows a clear cell-cycledependent expression at mitosis, largely controlled at the transcriptional level that involves canonical CDE/ CHR boxes located in the proximal survivin promoter (Kobayashi et al., 1999; . There is a pronounced upregulation of survivin during the G2/M phase of the cell cycle followed by a rapid decrease in G1. During mitosis, survivin localizes to different components of the mitotic apparatus, including centromeres in prophase, kinetochores of the metaphase and anaphase spindle, and the midbody during cytokinesis (Uren et al., 2000; Wheatley et al., 2001) . Survivin also associates with the multifunctional mitotic regulator Aurora B kinase, directing it to the kinetochores of metaphase chromosomes (Chen et al., 2003) .
One of the most significant and intriguing features of survivin is its differential expression in normal tissues versus cancer cells. It is critical for global normal embryonic development, as proven by the early embryonic lethality of mice with homozygous deletions in the survivin gene locus (Uren et al., 2000) . It is virtually absent from normal differentiated cells; however, it is expressed in certain highly proliferative areas within normal tissues, including vascular endothelial cells (Conway et al., 2003) , hematopoietic cells (Fukuda et al., 2002) , and neural stem cells ( Pennartz et al., 2004) . Inactivation of survivin in these normal cells appears to have detrimental effects. In contrast to most differentiated nontransformed cells, however, it is highly expressed in virtually every human tumor. Interestingly, two of the alternatively spliced products of the survinin gene locus show a differential expression in cancer, but not in normal tissues (Krieg et al., 2002; Mahotka et al., 2002a; Yamada et al., 2003) . This differential expression can be correlated with disease severity and treatment outcome, suggesting that each of these isoforms may serve a unique function in tumorigenesis.
In this work, we provide insight into the mechanism of survivin function in tumor cells and propose that it interacts directly with two of its splice variants. We use human medulloblastoma cells as a model of study and hypothesize that these survivin complexes may serve functionally distinct roles in cancer.
Results

Survivin regulates cytokinesis in medulloblastoma cells
Survivin is expressed in several neural-derived malignancies, including gliomas, ependymomas, astrocytic tumors, and neuroblastomas (Islam et al., 2000b; Chakravarti et al., 2002; Altura et al., 2003) . Recently, survinin was also identified in a SAGE array as one of the highest expressed transcriptomes in a population of normal neuronal stem cells isolated from the subventricular zone (SVZ) of adult mouse brains (Pennartz et al., 2004) . Previously, we characterized its expression by immunohistochemistry in pediatric brain tumors that localize to the SVZ region (Altura et al., 2003) . We were interested in further exploring the role of survivin in central nervous system tumor development, thus we evaluated its expression in medulloblastoma, a tumor that is believed to arise from mutations in cerebellar granular precursor cells during development. In the process of our evaluation, we were puzzled by the pattern of expression in the transformed cells when compared with the normal cells. We chose the Daoy cell line as an in vitro model to examine these expression patterns in more detail. Daoy is a transformed cell line harboring a mutant p53 gene, originally derived from a tumor biopsy from a pediatric patient with a desmoplastic variant of medulloblastoma (Jacobsen et al., 1985) .
Proliferating Daoy cells were seeded on glass coverslips, fixed and stained with antibodies recognizing survivin and a-tubulin. Localization of endogenous survivin by immunofluorescence using confocal microscopy revealed a cell-cycle-associated pattern of expression ( Figure 2 ). Survivin was not detected during interphase (panel f, arrow), but high levels of expression were detected in G2/M, with distinct localization patterns during the different stages of mitosis. At prophase and prometaphase, survivin was primarily nuclear. During prophase (panel a), when the chromatin slowly condenses into well-defined chromosomes, survivin initiates its movement to the centromeres. At prometaphase (panel b), when the nuclear membrane dissociates and the spindle microtubules enter the nuclear region to form the kinetochore, survivin continues to associate with centromeres. At metaphase (panel c), when the chromosomes align between the spindle poles and are held in tension at the metaphase plate by the paired kinetochores, survivin clearly associates with the kinetochores of condensed chromosomes. At anaphase (panel d), the distance between the spindle poles increases and the paired kinetochores on each chromosome separate, allowing each chromatid to be pulled towards the poles. During this phase, the kinetochore microtubules shorten as the chromosomes approach the poles and survivin moves to the midplate, Figure 1 Structure-function of survivin splice variants. Common features to all splice forms at the amino terminus include the dimer interface and the BIR domain. Survivin-2B differs by the introduction of exon 2B but retains the ORF for the remainder of the Cterminus. The BH2 domain and mitochondrial localization signal of survivin-DEx3 are also indicated. A frameshift occurs in exon 3 of survivin 3B causing a premature stop of the protein with a distinct C-terminus Survivin splice variants interact with survivin H Caldas et al culminating at the well-defined midbody at telophase (panel e). At cytokinesis (panel f), survivin localizes to the midbody at the cleavage furrow.
Survivin-2B and survivin-DEx3 are endogenously expressed in Daoy and HeLa cells
The relative levels of some survinin splice variants have previously been assessed by PCR in human tumors and in mouse fetal tissues (Conway et al., 2000) . One splice variant was also identified at the protein level in mouse embryos using an antibody with an N-terminal epitope that should detect all known mouse variants (Conway et al., 2000) . Neither survivin-2B nor survivin-DEx-3 have previously been described at the protein level, most likely due to the prior lack of existing antibodies for these variant protein products and due to their relatively lower expression levels as compared with survivin.
In order to characterize the survivin isoforms in Daoy cells, we first verified their transcriptional expression by quantitative PCR. Transcripts for survinin, survinin-2B, and survinin-DEx-3 were detected from this cell line (Figure 3a) , suggesting that Daoy cells could be used for further studies of these alternative transcripts. Protein extracts isolated from the Daoy cells and from HeLa cells were separated by SDS-PAGE and immunobloted with a polyclonal antibody against survivin, a polyclonal antibody against survivin-2B, and a polyclonal antibody against survivin-DEx3. Protein bands corresponding to the correct size of survivin and survivinDEx3 were visualized, suggesting that these survivin isoforms are translated into stable proteins in these tumor cells (Figure 3b ). Survinin-2B was not detectable by Western blot in Daoy or HeLa cell lines; however, it was visualized within several fresh-frozen medulloblastoma tumor samples isolated from patients with this malignancy (unpublished results).
We further characterized the survivin proteins by immunofluorescence microscopy. Daoy cells were transiently transfected with an expression construct encoding a fusion protein of survivin and the red fluorescent protein HcRed. Localization of the exogenously expressed fusion protein was studied by direct immunofluorescence. Survinin-HcRed strongly localized to the cytoplasm in the transfected cells (Figure 4a ). We were unable to visualize survivin-HcRed in M-phase by immunofluorescence, however, cell cycle analysis showed that 20% of cells were in G2/M. Multinucleated cells were also frequently observed in the survivintransfected cells (30% compared with o5% of control cells), suggesting a defect in cytokinesis causally related to the elevated survivin levels ( Figure 4a ). As additional controls for these transfections, we transfected Flagsurvivin and GFP-survivin into Daoy cells and observed the same results with these constructs (Figure 4a ). In addition, proliferating HeLa cells were transfected with Hc-Red-survivin and an empty vector HcRed control. In these cells, HcRed-survivin localized to the cytoplasm in interphase, but followed the endogenous pattern of expression observed in Daoy cells in mitosis (Figure 4b ). (a) Survivin localizes to centromeres in prophase; (b) the nuclear membrane dissociates in prometaphase with survivin still associated with the centromeres; (c) at metaphase the chromosomes align in the equatorial plate and survivin is bound to the kinetochores, ensuring proper separation of sister chromatids; (d) at anaphase survivin is visible in the midplate region as the chromosomes move towards the poles; (e) at telophase survivin localizes to the midbody region where tubulin filaments associate, as the chromosomes reach the poles; (f) cytokinesis is marked by the depolarization of the spindles and redistribution of the tubulin filaments, the reformation of the nuclear envelope and cytoplasmic division, for which a cleavage furrow is generated where there is a high concentration of survivin and tubulin. Scale bar -10 mm Survivin splice variants interact with survivin H Caldas et al
Survivin activates a p53 aneuploid checkpoint in tumor cells
Multinucleation has been observed in a number of different cell lines under a variety of conditions. Of interest to our work, Aurora A, Plk1, and Aurora B have been shown previously to induce multinucleation when overexpressed in transfected cells (Mundt et al., 1997; Terada et al., 1998; Meraldi et al., 2002) . Multinucleated cells, in these studies, also showed a correspondingly high incidence of centrosome amplification, aneuploidy, and other cytokinesis defects, including a high frequency of interconnecting DNA bridges (Meraldi et al., 2002) . These effects are exacerbated in cells that do not have a functional p53 protein (Armit et al., 2002; Meraldi et al., 2002 Figure 1 ). In addition, when HeLa cells were treated with the cell death stimulator vincristine (VCR), p21 WAF1 protein was highly induced, indicative of a functional p53 protein in these cells, while no induction of p21 WAF1 was observed in Daoy cells under these same conditions (Supplemental Figure 1 ).
Survivin-2B, survivin-DEx3, and survivin interact and localize to the perinuclear membrane and to mitochondria
To characterize the localization pattern of exogenously expressed survivin-2B and survivin-DEx-3 in Daoy and HeLa cells, we utilized expression constructs consisting of GFP and FLAG survivin-2B and survivin-DEx3. Survivin-2B localized to both nuclear and cytoplasmic compartments in Daoy cells, but only to cytoplasm in HeLa cells ( Figure 5a , top panel). Survivin-DEx-3 localized exclusively to the nucleus in both cell types ( Figure 5a , bottom panel).
Since the different isoforms naturally coexist with survivin and they are transcribed from the same gene locus, we wanted to analyse the effects of exogenous expression of survivin in the presence of exogenously expressed survivin-2B and survivin-DEx3. For these experiments, we cotransfected GFP fusions of survivin-2B or survivin-DEx-3 with an HcRed fusion of survivin and visualized the subcellular localization of the fusion proteins by direct immunofluorescence in fixed cells. As a control for the large GFP fusion protein, the same experiments were also performed with FLAG and myc fusions.
Interestingly, the localization of survivin, survivin-2B, and survivin-DEx-3 differed when they were cotransfected when compared with individual transfections. In both Daoy and HeLa cell lines, survivin and survivin-2B complexes colocalized to defined cytoplasmic structures ( Figure 5b ). Similarly, survivin and survivin-DEx-3 complexes colocalized to the same structures ( Figure 5c ). The structures were perinuclear, appeared contiguous with the nuclear membrane, but expanded throughout the cytoplasm in most cases.
To provide further evidence for the heterodimerization of the survivin splice variants with survivin, we performed coimmunoprecipitation experiments of these proteins, following transfection. Immunoprecipitation (IP) of HeLa cells transfected with FLAG-survivin, using an anti-FLAG monoclonal antibody for the IP and polyclonal antibodies to survivin and survivin-DEx3 for the Western, demonstrated survivin and endogenous survivin-DEx3 in the complexes (Figure 5d ). To circumvent the difficulties with the detection of endogenous survivin-2B, a myc-tagged survivin-2B construct was coexpressed with FLAG-survivin. The complex was immunoprecipitated with an anti-FLAG antibody and detected with a polyclonal anti-myc-antibody ( Figure 5d ). These results support a direct interaction of these proteins and heterodimerization of these splice variants with survivin. Primers and probes for survivin, survivin-2B, and survivin-DEx3 were used to evaluate the expression of these transcripts in Daoy cells. Levels were normalized to gapdh and compared with levels expressed from cDNA isolated from normal human cerebellar tissue. Survivin is the highest expressed isoform, followed by survivin-DEx3, and survivin-2B, respectively. (b) Protein extracts made from Daoy cells and HeLa cells were separated on an 18% SDS-PAGE. Gels were electroblotted and immunoprobed with anti-survivin antibody, an anti-survivin-2B antibody, and an antisurvivin-DEx3 antibody. Endogenous survivin and survivin-DEx3 were easily visualized. For comparison, an immunoblot is shown from HeLa cells transfected with survivin-myc, survivin-2B-myc, or survivin-DEx3-myc and probed with an anti-myc antibody To determine which subcellular compartments contained the survivin splice variant complexes, we used immunofluorescent markers for various subcellular organelles. Markers for the endoplasmic reticulum (anti-PDI) and lysosomes (LysoTracker) did not colocalize with the survivin complexes following cotransfection of the survivin splice forms, suggesting that the complexes were not associated with these organelles (Figure 6a ). Staining with MitoTracker ( Figure 6b ) and a Golgi marker (GM130, Figure 6a ) showed partial colocalization with the survivin/survivin-2B and survivin/survivin-DEx-3 complexes, while this was not observed when the proteins were transfected individually. To verify the mitochondrial localization of survivin and its splice forms, we also performed subcellular fractionation of these cells into and prometaphase (c) survivin localized to centromeres; at metaphase (d) survivin localized to the kinetochores; at telophase (e) survivin was visible in the midplate region; and at cytokinesis (f) survivin was seen in the cleavage furrow where cytoplasmic division occurs. Scale bar-5 mm Survivin splice variants interact with survivin H Caldas et al nuclear, mitochondrial, and cytoplasmic fractions and then performed a Western blot analysis using the polyclonal anti-survivin antibody. Survivin localized to all of these subcellular regions (Figure 6c ), supporting our immunofluorescence results. Low levels of survivin-DEx-3 also localized to the mitochondria (Figure 6c ), again supporting the immunofluorescence results.
To eliminate the possibility that the structures we observed were simply a nonspecific manifestation of abnormally folded GFP fusion proteins, we also performed immunolabeling of cotransfected cells with an antibody against vimentin. As previously described, aggresomes are formed in response to cytoplasmic aggregation of misfolded proteins. During the formation of aggresomes, vimentin fibers are redirected to the Flag-survivin or Flag-survivin and survivin-2B-myc were lysed and subjected to coimmunoprecipitation with a monoclonal antibody directed against the Flag epitope or an IgG control antibody. The IP complexes were then subjected to electrophoretic separation through a 10-20% Tris-Tricine gel, transferred onto nitrocellulose, and immunoprobed with a polyclonal anti-survivin antibody, an anti-myc antibody, or an anti-survivin-DEx3 antibody. Survivin and the two survivin isoforms were easily visualized in the Flag-IP lanes, while no bands corresponding to the survivin proteins were seen in the control lanes Survivin splice variants interact with survivin H Caldas et al aggresome area (Johnston et al., 1998) . This process, often referred to as cellular indigestion, occurs when the production of aggregation-prone proteins exceeds the cell's capacity to eliminate them (Johnston et al., 1998) . Aggresomes are one of the manifestations of cellular indigestion in cytoplasmic compartments. Vimentin did not colocalize with the survivin complexes, confirming that the dimerization of survivin and the isoforms did not occur as a consequence of cellular 'indigestion' (Supplemental Figure 2) . The fact that the survivin complexes localize to different subcellular compartments compared to the singly transfected proteins argues for the formation of heterodimers of survivin and its splice variants.
To determine the functional role of the heterodimers, we performed cell viability and apoptosis assays following challenge with the chemotherapeutic drug VCR, commonly used in the treatment of medulloblastomas. We transfected Daoy cells with a vector control, survivin, or survivin-DEx3 individually and also cotransfected these cells with survivin and survivin-DEx3 together. The results indicated that both survivin and survivin-DEx3 can protect cells from programmed cell death (PCD), as shown by the greatly increased viability of cells transfected with these constructs compared with control ( Figure 7 ). This protection was further increased (P ¼ 0.03) when cells were cotransfected with survivin and survivin-DEx3, at both 24 and 48 h after VCR treatment (Figure 7) . The apoptotic index for cells transfected with survivin, survivin-DEx3, and survivin together with survivin-DEx3, as determined by Annexin V staining, was 6.3, 8.3 and 3.2%, respectively. These results further support the antiapoptotic functional role for the survivin splice variant complexes.
Disruption of survivin complexes results in growth defects and apoptosis
In order to further evaluate the functional role of the survivin proteins in Daoy cells, we used siRNAs generated against all three survivin splice variants to reduce the levels of the survivin proteins expressed in these cells. Proliferating Daoy cells were transiently transfected with siRNAs to the survivin isoforms or empty-vector control plasmids, under the control of an H1 RNA polymerase promoter. An expression construct encoding EGFP was cotransfected with the siRNAs in order to select for a population of cells that exclusively expressed the siRNAs. At 24 h after transfection, cells were sorted by FACS and seeded onto 12-well plates. Quantitative analysis of RNA for each of the survivin isoforms revealed a substantial decrease in the levels of transcripts of the three survivin species after 24 h (Figure 8a) . Growth of siRNA-treated cells was markedly diminished, while growth of control cells was unaffected (Figure 8b ). The differences in cell number between siRNA-treated cells and control cells were significant at 24 h (Po0.001), 48 h (Po0.001), 72 h (Po0.001), and 96 h (Po0.001) supporting the hypothesis that a lack of survivin proteins results in defects in cell division and growth. In addition to the growth defect, cells treated with survivin-siRNAs had an increased rate of apoptosis when compared with control cells. At 30 h after transfection with either siRNAs or with control vector, the amount of apoptosis seen in the siRNA-treated cells was threefold above that seen in the control cells, as assayed by Annexin V staining ( Figure  8c and d). Since elimination of survivin and survivin splice variants in Daoy cells results in both a cell division defect and apoptosis, this supports the hypothesis that these proteins have multiple functions in these malignant cells. It also supports the use of survivin-targeted therapy for treatment of medulloblastoma tumors.
Discussion
Survivin has been implicated as a critical player in fundamental cellular processes, including cell division and apoptosis, during both normal embryonic development and in a majority of human tumors. As it is transcriptionally silent in most differentiated, nondividing cells, survivin antagonists represent a unique target for biologic therapy in these malignancies. Investigations that shed light on the interaction of survivin with its partner-proteins and the subcellular location where these interactions take place are crucial for validating survivin as a cancer therapeutic target. In this study we evaluated the subcellular localization of survivin in Daoy cells harboring a mutant p53 protein and in HeLa cells harboring a wild-type p53 protein. We show that survivin can form complexes with two of its alternatively spliced protein products and that the formation of these complexes results in a novel localization pattern within the tumor cells. This Figure 6 Partial colocalization of survivin complexes with mitochondria and Golgi. (a) Daoy cells transfected with GFP-survivin, GFP-survivin-DEx3 or Flag-survivin and GFP-survivin-DEx3 were incubated with LysoTracker (panel 3) or subjected to immunofluorescence with marker antibodies for the Golgi apparatus (GM130, panel 1) or ER (PDI, panel 2). Partial colocalization was observed with the marker for the Golgi apparatus (yellow pixels, arrows), whereas no colocalization was observed with the ER marker or late endosome/early lysosome marker (green pixels, arrows). Scale bar -10 mm. (b) Daoy cells transfected with GFPsurvivin, GFP-survivin-DEx3, or Flag-survivin and GFP-survivin-DEx3 were incubated with MitoTracker CMXRos prior to fixation. The cells were visualized by direct fluorescence. Survivin (green) localized to the cytoplasm, and survivin-DEx3 (green) to the nucleus. MitroTracker (red) did not colocalize with these survivin species. In cells cotransfected with survivin and survivin-DEx3, the survivin complexes colocalized with a subset of mitochondria both in the periphery of the nucleus and in other cytoplasmic regions (arrows), as indicated by the yellow pixels. Scale bar -10 mm. (c) HeLa cells were fractionated into mitochondrial, nuclear, and cytoplasmic fractions, as described in the Materials and methods section. Equal amounts of protein from each compartment (200 mg each) were separated on an 18% SDS-PAGE gel, transferred to nitrocellulose and probed with a polyclonal anti-survivin antibody. Survivin isoforms localize to all three compartments, as indicated Survivin splice variants interact with survivin H Caldas et al change in localization suggests the possibility of 'functionally distinct' survivin complexes that may arise within tumor cells that aberrantly express survivin proteins at high levels.
Aberrant expression of survivin results in cell division defects
Failed cytokinesis and an increased incidence in polyploidy has been observed previously in cells treated with survivin antagonists, including antisense oligonucleotides and survivin dominant-negative mutants Chen et al., 2000) . In E4.5 embryos with homozygous deletion of the survivin locus, the formation of giant cells with large and morphologically unusual nuclei were observed, in addition to polyploidy (Uren et al., 2000) . Interestingly, in our study, cells transfected with constitutively expressing survivin fusion constructs also showed multinucleation defects in an excess of 50% of cells expressing a mutant p53 protein. This Daoy cells transfected with vector control (pcDNA4/TO/mycHisB), survivin-myc, survivin-DEx3-myc, or survivin-myc plus survivin-DEx3-myc were treated with 2 nM VCR for 24 h (white bars) or 48 h (black bars). Cell viability was assayed by trypan blue exclusion observation is consistent with defects in cytokinesis that occur in cells lacking survivin (Uren et al., 2000) . It also supports prior work that has shown that two tandem checkpoint mechanisms normally cooperate to ensure euploid cell progeny in healthy cells: one that delays completion of the individual steps of mitosis until the process can be accurately finished, and a second that arrests cells when the first process has failed (Margolis et al., 2003) . While the first failure may arise from a number of checkpoint failures, in this case it arises due to aberrant expression of the chromosomal passenger protein, survivin. The second failure arises from the suppression of a p53-dependent G1 surveillance mechanism (Margolis et al., 2003) . Results from these experiments suggest that the levels of proteins expressed from the survinin gene locus must be tightly regulated for cell division and growth to occur normally, and for the cell to maintain a euploid state, especially in the background of mutations in critical tumor suppressor genes, such as p53 or pRB.
Survivin splice variants colocalize with survivin in the mitochondria
Expression studies in HepG2 cells using GFP-fusion constructs of survivin, survivin-2B, and survivin-DEx-3, previously showed that survivin and survivin-2B localized to the cytoplasm, while survivin-DEx-3 localized to the nucleus (Mahotka et al., 2002b) . Owing to the different subcellular compartments of these proteins, it was hypothesized that survivin and its isoforms interacted indirectly, through binding to common partners such as polymerized tubulin (Islam et al., 2000a) . Here, we show that coexpression of survivin with either 2B or DEx-3 results in an alteration in the subcellular localization of the protein complexes with the formation of perinuclear-and mitochondrial-associated structures. Together with the coimmunoprecipitation data demonstrating that the survivin splice variants can heterodimerize, our observations dispute the prior hypothesis that survivin requires intermediary proteins for its various functions, but instead argues for a direct association of the splice variants themselves with survivin.
The structure of the survivin-DEx3 protein includes a mitochondrial localization signal and a BH2 domain, the latter, which is required for binding to Bcl-2 and inhibiting mitochondrial-dependent apoptosis (Table 1) . PSORTII analysis also predicts a 13% probability of survivin and survivin-2B localizing to mitochondria, which could account for the recruitment of these survivin proteins to these organelles (Table 1 ). Our studies show that survivin splice variant complexes localize to mitochondria. By contrast, the individual survivin proteins when expressed alone do not localize to these organelles. This supports the hypothesis that heterodimerization of survivin and the survivin splice products may be required for the recruitment of the complexes to the mitochondria. Previous crystal structural analyses also support the hypothesis that survivin can dimerize through its BIR domains (Verdecia et al., 2000) .
Role of survivin complexes in mitochondrial-dependent apoptosis
Following an apoptotic stimulus, Bax and Bid bind to the mitochondrial membrane leading to membranedepolarization, release of cytochrome c, and subsequent activation of caspase-9 (Jurgensmeier et al., 1998; Kluck et al., 1999) . Activated caspase-9 then activates terminal caspase-3 that cleaves proteins involved in cytoskeletal and nuclear structure (Green and Reed, 1998) . IAPs, such as XIAP and c-IAP, bind to caspases to prevent apoptosis from proceeding (Verhagen et al., 2001) . Although structural studies suggest that survivin does not bind to caspases, several studies have demonstrated a role for survivin as an inhibitor of Table 1 Predicted subcellular localization and features of the four survivin species (PSORTII (Horton and Nakai, 1997) and TargetP (Nielsen et al., 1997; Emanuelsson et al., 2000) ) Survivin splice variants interact with survivin H Caldas et al mitochondrial-dependent apoptosis. A survivin-GST fusion protein has previously been shown to bind to the mitochondrial protein Smac/DIABLO, a proapoptotic protein that is released following apoptotic stimulation (Chen et al., 2000; Verhagen et al., 2000) .
Functionally, it has been demonstrated that a dominant-negative mutant of survivin can activate mitochondrial-dependent apoptosis through release of Smac/DIABLO in HeLa cells (Song et al., 2003) . In vivo, mice with heterozygous deletions in the survivin gene locus have also been shown to be more sensitive to mitochondrial-dependent hepatocellular apoptosis, when compared with wild-type mice (Conway et al., 2002) . In those studies, localization of survivin to the mitochondria of hepatocytes was observed in response to Fas ligand. Additionally, a homolog of survivin-DEx3 (K7) exists in the Kaposi's sarcoma-associated herpesvirus (KHSV) genome that localizes to mitochondria and inhibits apoptosis by associating with Bcl-2 through its BH2 domain (Wang et al., 2002) . Most recently, during the revision of this paper, Altieri and co-workers showed that a specific mitochondrial pool of survivin protects cells from cell death by preventing the activation of initiator caspase-9 (Dohi et al., 2004) . In this work, the authors also discuss data that other IAPs, including cIAP2 and XIAP, have been found in mitochondrial extracts of cancer cell lines. Interaction of the survivin splice variant complexes within the mitochondria, shown in our study, segues well with the findings of these prior studies and implicates survivin splice variants in the mitochondrial-dependent apoptotic pathway. We also show that medulloblastoma cells treated with VCR had an increase in viability and a decrease in PCD when survivin and survivin-DEx3 were coexpressed. This supports a hypothesis that survivin : -survivin-DEx3 heterodimer complexes may act synergistically to inhibit mitochondrial-dependent apoptosis in these cells.
Functional consequences of survivin-directed therapy
Despite the enthusiasm for survivin-targeted therapy in the treatment of cancer, there has been some degree of frustration in the advancement of these compounds to clinical trials, partly due to their inconsistent specificity on effecting cell death pathways (Altieri, 2003) . In addition, it has also been demonstrated that high survivin levels are not restricted to transformed cells, but are found in proliferating normal cells, such as hematopoietic stem cells (Fukuda et al., 2002) and vascular endothelial cells (Conway et al., 2003) . Survivin is also upregulated in normal immune cells following stress (Altznauer et al., 2004) . Expression in these normal cells could present a significant deterrent to the use of survivin-targeted therapy in cancer due to its potential toxicity, especially if delivered systemically. Our data, demonstrating that survivin-siRNAs targeting both survivin and the survivin splice variants can interfere with both the mitochondrial-dependent apoptosis pathway and cell division, support the hypothesis that the function of survivin may be dependent on its interaction with its partner proteins. Our additional findings that the survivin splice-variants, when complexed with survivin, interact with survivin within the mitochondria where apoptosis is initiated, lend further support to this hypothesis. These data suggest that careful consideration must be given to the relative expression levels of the survivin splice forms in tumor cells when designing targeted therapies that involve the survivin molecule.
Materials and methods
Plasmids and siRNAs
EGFP survivin, EGFP-survivin2B, and EGFP-survivin-DEx-3 have been previously described (Mahotka et al., 2002b) ; HcRed-survivin was generated by subcloning the survivin cassette from pEGFP-survivin into pHcRed. The KpnI/BamHI fragment from the EGFP survivin, survivin-2B, and survivinDEx3 containing vectors was used for ligation into pcDNA4/ TO/myc-HisB (Invitrogen). FLAG fusions were generated by PCR amplifying survivin, survivin-2B, and survivin-DEx3 cDNA using primers containing EcoRI and BamHI sites. These were ligated into the EcoRI and BamHI sites of the pFlag-CMV-6C (Sigma) polylinker. Human survivin-specific siRNAs were designed using Oligoengine software (OligoEngine, Inc., Washington, USA) and cloned into a pSUPER vector (Brummelkamp et al., 2002) . For functional assays, Daoy cells were transfected with survivin-myc, survivin-DEx3-myc, and empty vector control using effectene. 24 h after transfection, 2 nM VCR sulfate (Vincasar PFS s , Sicor Pharmaceuticals Inc.) was added to the medium. Cells were assayed for viability by trypan blue exclusion. Apoptotic index was measured by Annexin-V-FLUOS staining, as described above. Experiments were performed in triplicate.
Immunofluorescence
Transiently transfected HeLa and Daoy cells grown on 13 mm glass coverslips were fixed in 4% paraformaldehyde at room temperature for 10-30 min. For direct fluorescence, the cells were washed, nuclei stained with a solution of 5 mg/ml Hoechst 33258, and mounted in Vectashield (Vector Labs). For indirect immunofluorescence, cells were permeabilized with 0.2% Triton X-100 for 30 min, washed in phosphate buffered saline (PBS), blocked with 5% normal goat serum, and incubated with primary antibodies (survivin, Flag, alpha tubulin, vimentin, myc, GM130, PDI) made in a solution of 3% normal goat serum. The cells were washed and incubated with a secondary antibody (anti-mouse FITC, anti-mouse Alexa Fluor594, anti-rabbit FITC), washed, stained with Hoechst 33258, and mounted as described above. For detection of endogenous survivin, after primary antibody incubation with polyclonal anti-survivin, a secondary antirabbit biotin and a tertiary NeutrAvidin Texas Red (Molecular Probes) were used before staining with Hoechst and mounting, in order to amplify the signal from endogenous survivin expression. Confocal microscopy was performed on a Zeiss LSM510 META, and image analyses performed using the standard operating system software provided with the microscope. A Plan Apochromat Â 63/1.4 Oil/DIC objective was used for all experiments.
Mitochondria and lysosome staining
Transfected Daoy cells seeded on glass coverslips, as described above, were stained with MitoTracker or LysoTracker to detect mitochondria and lysosomes, respectively. To stain mitochondria, MitoTracker Red CMXRos was diluted in growth media at a concentration of 500 nM and added to the cells for 45 min at 371C. This process stains mitochondria in cells undergoing active respiration. To stain lysosomes, LysoTracker Red DND-99 was diluted in growth media at a concentration of 100 nM and added to the cells for 30 min at 371C. After these incubations, both MitoTracker and LysoTracker stained cells were washed, fixed, stained with Hoechst 33258, and mounted as described above.
Subcellular fractionation
Subcellular fractions were prepared by the method of Bronfman et al. (1998) . At the time of harvest, the media was removed from the cells, and each plate was washed 3 times with PBS. The plates were then individually treated with 1 ml of 1 mg/ml digitonin (Sigma Chemical Co., St Louis, MO, USA) dissolved in 0.25 M sucrose, 3 mM imidazole, pH 7.4 (sucrose/imidazole buffer), and immediately observed under the microscope. The digitonin buffer was removed within 15-30 s, and the plates were washed with an additional 2.0 ml of sucrose/imidazole buffer. The digitonin-containing buffer and the subsequent washes were combined as the cytoplasmic fractions. The remaining cellular material was scraped from the plates using 1 ml of sucrose/imidazole buffer and homogenized with a Dounce homogenizer, using 12 strokes of the tight pestle, which disrupted the cytoskeleton. The resulting homogenates were centrifuged at 10 000 g for 3-5 s. The supernatants were removed, and the pellets washed in 0.5 ml of sucrose/imidazole buffer, centrifuged again for 3-5 s, the supernatants discarded, and the pellets containing the nuclei were suspended in 0.3 ml of sucrose/imidazole buffer. The supernatants from the first 3-5 s centrifugation were centrifuged again at 10 000 g for 15 min. The supernatants were removed and the pellets were washed in 0.5 ml of sucrose/ imidazole buffer and centrifuged again for 15 min. The supernatants were discarded, and the pellets containing the mitochondria were suspended in 0.3 ml of sucrose/imidazole buffer. Subcellular fractions used for western blot analyses were treated with 0.1% Triton X-100 to solubilize the organelle membranes.
Western blotting
Protein extracts were isolated from HeLa and Daoy cells using SDS boiling method, protein concentrations determined by D C protein assay (Bio-Rad); 150 mg of protein were separated on a 18% SDS-PAGE and transferred onto a nitrocellulose membrane using a semi-dry transfer apparatus, at 15 V for 1 h. The membrane was probed with anti-survivin polyclonal antibody (1 : 5000), anti-survivin-2B (1 : 1000), anti-survivinDEx3 (1 : 1000) and HRP-conjugated anti-rabbit IgG (1 : 5000), and detected using the advanced ECL System (Amersham). Survivin-myc transfected blots were probed with an anti-myc antibody (Sigma, 1 : 5000) and HRP-conjugated anti-rabbit IgG (1 : 5000), and detected using the ECL System (Amersham). Molecular weight protein standards (Invitrogen) were run alongside the protein samples for size determination.
Coimmunoprecipitation
HeLa cells transfected with Flag-survivin or Flag-survivin and survivin-2B myc were collected in Cell Lysis Buffer (100 mM Tris-HCl pH8.0, 100 mM NaCl, 0.5% Triton X-100, 0.2 mM PMSF) and incubated at 41C for 30 min. The cell lysate was clarified by centrifugation and the clarified supernatant dissolved 1 : 5 in co-IP buffer (50 mM Tris-HCl pH7.5, 15 mM EGTA, 100 mM NaCl, 0.1% Triton X-100, 1 Â protease inhibitors cocktail, 1 mM DTT, 1 mM PMSF). The equivalent of 400 mg of lysate total protein was incubated with 2 mg of anti-Flag M2 antibody at 41C for 1 h with constant rotation. As a control the same amount of lysate protein was incubated in the absence of antibody. In all 50 ml of agarose-conjugated protein A (Invitrogen) was added and the mixture incubated for a further hour in the same conditions. The proteinantibody-protein A complexes were pulled down by centrifugation and subjected to three washes with co-IP buffer. The pellet containing the protein complexes was suspended in Tricine loading buffer (200 mM Tris-HCl, pH6.8, 40% glycerol, 2% SDS, 0.04% Coomassie Blue G-250). The proteins were analysed through electrophoretic separation in a 10-20% Tris-Tricine gel (Bio-Rad), electroblotted onto nitrocellulose and immunoprobed with the anti-survivin, antimyc, and anti-survivin-DEx3 antibodies, as described above. Detection was performed using the ECL kit (Amersham). Protein standards were used for size determination.
Antibodies
Anti-survivin antibodies used in these studies were obtained from Santa Cruz Biotech (FL142) or Novus Biologicals (NB201, NB203); antibodies against survivin-2B and survivin-DEx3 were obtained from abcam (ab13762 and ab3731); antibodies against alpha-tubulin and monoclonal anti-Flag M2 were purchased from Sigma; the p21 WAF1 antibody and the AIF antibody were obtained from Santa Cruz (sc-9416 and sc-6246); the p53 antibody was obtained from Oncogene (OP43); the Golgi marker antibody, GM130, was obtained from BD Pharmingen and the ER-marker antibody, anti-PDI, from Affinity Bioreagents; for the detection of aggresomes the vimentin monoclonal antibody was obtained from DakoCytomation; and the myc-tag antibody was purchased from Cell Signaling. Secondary antibodies anti-mouse FITC, antirabbit FITC and anti-rabbit biotin were purchased from Santa Cruz Biotech. Anti-mouse Alexa594 and NeutrAvidin Texas Red were both purchased from Molecular Probes.
RNA preparation and quantitative real-time PCR analysis
Daoy cells transfected with survivin-siRNA or pSUPER control were sorted by FACS and then harvested and total RNA was isolated using Trizol reagent (Invitrogen). Poly(A) RNA was purified using the Oligotex dT kit (Qiagen). cDNAs were generated with Omniscript Reverse Transcription kit (Qiagen) using 100 ng of poly(A) purified RNA and N6 primer (Qiagen Operon). Quantitative real-time PCR reactions using Taqman probes (FAM/TAMRA) were run in triplicate on an ABI Prism 7000 Real-time PCR machine (Applied Biosystems). Control GAPDH reactions (Applied Biosystems) were also run to normalize DCt values. Fold change was calculated as 2 (ÀDDCt) .
Statistical analysis
The statistical significance of the differences in cell viability between survivin-transfected and survivin plus survivin-DEx3-transfected cells was determined by analysis of variance between groups (ANOVA). In addition, we used an unpaired Student's ttest to assess the differences in apoptosis between the siRNAtreated cells and the empty-vector control-treated cells.
Abbreviations MEF, mouse embryo fibroblast; GFP, green fluorescent protein; IAP, inhibitor of apoptosis; BIR, baculovirus inhibition of apoptosis protein repeat; siRNA, small interfering RNA; PCD, programmed cell death; VCR, vincristine.
